dc.contributor.author |
Ozzengin, Berfin |
|
dc.contributor.author |
Ergun, Sercan |
|
dc.date.accessioned |
2023-01-06T11:04:35Z |
|
dc.date.available |
2023-01-06T11:04:35Z |
|
dc.date.issued |
2021 |
|
dc.identifier.citation |
Ozzengin, B., Ergun, S. (2021). Role of miR-6814-5p for the formation of T5, a heparanase variant, in renal cell carcinoma. Cukurova Medical Journal, 46(4), 1532-1536.Doi:10.17826/cumj.984271 |
en_US |
dc.identifier.isbn |
2602-3032 |
|
dc.identifier.isbn |
2602-3040 |
|
dc.identifier.uri |
http://dx.doi.org/10.17826/cumj.984271 |
|
dc.identifier.uri |
https://www.webofscience.com/wos/woscc/full-record/WOS:000728748600027 |
|
dc.identifier.uri |
http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/3453 |
|
dc.description |
WoS Categories : Medicine, General & Internal
Web of Science Index : Emerging Sources Citation Index (ESCI)
Research Areas : General & Internal Medicine
Open Access Designations : gold, Green Submitted |
en_US |
dc.description.abstract |
Purpose: The aim of this study is to investigate whether the overexpression of human heparanase protein (HPSE) alternative variant protein called T5 is caused by increased expression of miR-6814-5p in human renal cell carcinoma (RCC) cases. In addition, the possible correlation between the clinical parameters of RCC cases and the expression levels of T5 and miR-6814-5p was evaluated. Materials and Methods: T5 and miR-6814-5p expression analysis was performed on ready-to-use RCC cDNA panel by qPCR method. This panel included 48 cDNA samples obtained from tumor tissues of 10 stage-1, 5 stage-2, 13 stage-3 and 11 stage-4 RCC patients and normal kidney tissues from 9 healthy individuals. Results: There was no significant correlation between TNM stages, Fuhrman nuclear grade and histological type and miR-6814-5p and T5 expressions. The expression level of miR-6814-5p in RCC tumor tissues was about 8-fold higher and the T5 expression level about 5-fold higher than healthy controls. MiR-6814-5p and T5 expression changes were statistically significantly correlated with neutrophil/lymphocyte ratio of RCC cases. Conclusion: MiR-6814-5p may play a role in the formation mechanism of T5 in RCC. |
en_US |
dc.description.sponsorship |
Funding Orgs : TUBITAK 2209-A project [1919B011901762]
Funding Name Preferred : TUBITAK 2209-A project(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))
Funding Text : This study was carried out within the scope of TUBITAK 2209-A project, numbered 1919B011901762. |
en_US |
dc.language.iso |
eng |
en_US |
dc.publisher |
CUKUROVA UNIV, FAC MEDICINE ADANA |
en_US |
dc.relation.isversionof |
10.17826/cumj.984271 |
en_US |
dc.rights |
info:eu-repo/semantics/openAccess |
en_US |
dc.subject |
PREDICTION |
en_US |
dc.subject |
Renal cell carcinoma; heparanase; gene expression regulation; miR-6814-5p |
en_US |
dc.title |
Role of miR-6814-5p for the formation of T5, a heparanase variant, in renal cell carcinoma |
en_US |
dc.type |
article |
en_US |
dc.relation.journal |
CUKUROVA MEDICAL JOURNAL |
en_US |
dc.contributor.department |
Ordu Üniversitesi |
en_US |
dc.identifier.volume |
46 |
en_US |
dc.identifier.issue |
4 |
en_US |
dc.identifier.startpage |
1532 |
en_US |
dc.identifier.endpage |
1536 |
en_US |